The expression levels of APP, CDC5L, MPHOSPH6, MRPS31, and MTREX in PRAD tissues were observed to be lower than those in corresponding non-cancerous tissues (Figure 4a). The gene discussed is CDC5L; the disease is prostate adenocarcinoma.